Financial Avengers’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.18M Buy
131,989
+13,882
+12% +$363K 1.32% 18
2026
Q1
$3.32M Buy
118,107
+8,210
+7% +$219K 1.51% 18
2025
Q4
$2.74M Buy
109,897
+11,605
+12% +$293K 1.12% 19
2025
Q3
$2.5M Buy
98,292
+8,500
+9% +$210K 1.08% 20
2025
Q2
$2.18M Buy
89,792
+14,524
+19% +$339K 1.01% 19
2025
Q1
$1.91M Buy
75,268
+22,684
+43% +$594K 0.97% 21
2024
Q4
$1.4M Buy
52,584
+24,642
+88% +$668K 0.66% 23
2024
Q3
$809K Buy
27,942
+9,568
+52% +$279K 0.4% 26
2024
Q2
$514K Buy
18,374
+6,284
+52% +$173K 0.27% 25
2024
Q1
$335K Buy
12,090
+5,244
+77% +$146K 0.18% 27
2023
Q4
$197K Buy
6,846
+86
+1% +$2.6K 0.12% 30
2023
Q3
$224K Buy
6,760
+182
+3% +$6.44K 0.15% 29
2023
Q2
$241K Buy
6,578
+63
+1% +$2.45K 0.16% 26
2023
Q1
$266K Buy
6,515
+60
+0.9% +$2.59K 0.2% 25
2022
Q4
$331K Buy
6,455
+48
+0.7% +$2.3K 0.27% 23
2022
Q3
$280K Sell
6,407
-2
-0% -$97 0.23% 24
2022
Q2
$336K Buy
6,409
+49
+0.8% +$2.5K 0.27% 23
2022
Q1
$329K Sell
6,360
-950
-13% -$49.3K 0.21% 25
2021
Q4
$432K Buy
7,310
+176
+2% +$8.72K 0.27% 22
2021
Q3
$307K Buy
7,134
+33
+0.5% +$1.46K 0.21% 24
2021
Q2
$278K Buy
7,101
+63
+0.9% +$2.45K 0.19% 25
2021
Q1
$255K Buy
7,038
+111
+2% +$3.94K 0.19% 23
2020
Q4
$255K Buy
+6,927
New +$254K 0.21% 22

Other funds holding PFE

Financial Avengers's PFE Position: Q2 2026 in Review

Financial Avengers increased its Pfizer (PFE) stake by 12% in Q2 2026, buying an estimated $363K and bringing the position to 131,989 shares worth $3.18M. The position accounts for 1.32% of the portfolio, ranked #18.

Financial Avengers first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.32M in Q1 2026. 2,824 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Financial Avengers held 131,989 shares of Pfizer worth $3.18M as of Q2 2026.
  • Financial Avengers bought 13,882 Pfizer shares in Q2 2026, an estimated $363K.
  • Pfizer made up 1.32% of Financial Avengers's portfolio in Q2 2026, its #18 holding.
  • Financial Avengers first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Financial Avengers's Pfizer position peaked at $3.32M in Q1 2026.
  • 2,824 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Financial Avengers's 13F filing for Q2 2026, filed 19 Aug 2026.